PROCEPT BioRobotics Corporation (PRCT) vs Tandem Diabetes Care, Inc. (TNDM)
PROCEPT BioRobotics Corporation and Tandem Diabetes Care, Inc. are both Medical Devices companies. PROCEPT BioRobotics Corporation and Tandem Diabetes Care, Inc. are of similar size ($1.1B and $1.0B). PROCEPT BioRobotics Corporation grew revenue faster over the last twelve months: 22.7% against 3.96%. Tandem Diabetes Care, Inc. has the higher net margin (−6.08% vs −32.5%) and the higher return on invested capital (−10.3% vs −43.6%). Across the 18 metrics below, PROCEPT BioRobotics Corporation leads on 9 and Tandem Diabetes Care, Inc. on 9.
Valuation
Profitability
| Metric | PRCT | TNDM | Medical Devices median |
|---|---|---|---|
| Gross margin | 64.22% | 56.01% | 56.01% |
| Operating margin | (33.86%) | (4.40%) | (15.03%) |
| Net margin | (32.54%) | (6.08%) | (20.40%) |
| Free cash flow margin | (25.17%) | (2.56%) | (7.24%) |
| Return on equity | (30.24%) | (48.03%) | (15.32%) |
| Return on assets | (22.12%) | (6.24%) | (19.72%) |
| Return on invested capital | (43.57%) | (10.33%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack